Skip to main content
search

Conference: 2025 MFDS-KCDA Annual Conference

Date: December 11, 2025

Location: Seoul, Korea

Booth: #6

Join Certara at MFDS-KCDA Annual Conference in Seoul

We are excited to participate as an exhibitor at 2025 MFDS-KCDA Annual Conference on December 11 in Seoul, Korea. The Korea Clinical Development Association (KCDA) aims to enhance the level of domestic new drug development and clinical trials. For approximately 30 years, it has provided a platform for sharing clinical trial knowledge and experience among pharmaceutical companies, CROs, and clinical trial sites. It is making multifaceted efforts to establish a domestic clinical trial infrastructure and improve its quality.

Visit us at Booth #6 to meet our scientific experts, discover cutting-edge biosimulation innovations, and learn how we’re transforming drug development through smarter, faster solutions. Our exhibition features expert presentations, research posters, and interactive engagement opportunities showcasing Certara’s leadership in pharmaceutical sciences. Join us to explore the future of drug development at this premier industry event.

Success of early clinical trials are linked to strategic planning

  • Robust data insights – Transform complex data into actionable insights through advanced pharmacometric modeling and expert consulting services.
  • Regulatory readiness – Execute your comprehensive clinical development plan, streamline data validation, and prepare regulatory-ready submissions.

Your trusted guide to early clinical success

  • CoAuthor™: Accelerate the creation of regulatory documents with AI-generated content, freeing up writers for key analysis, messaging, and refinement.
  • Pinnacle 21®: Increase the speed and quality of your clinical trail submission data with the Pinnacle 21® Clinical Data Management & Automation Suite.

Meet us there

Pre-book a free, no-obligation meeting with our technical experts at the show. Simply provide a few details and we’ll come armed with the right resources to best advise you.